In Brief: Columbia Labs
This article was originally published in The Tan Sheet
Executive Summary
Columbia Labs: Private placement of 1.4 mil. shares of common stock raises $12.9 mil. for the Miami-based developer of women's OTC and prescription products. Allen & Company served as the placement agent. Columbia Labs will use the proceeds for "potential acquisitions of products and technology, clinical studies and working capital," the company stated March 12...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning